InsidersTradesSigma
Interpace Biosciences, INC.: insider trades · United States · SEC (Form 4)
SEC:interpace-biosciences-inc-b80592US·SEC (Form 4)Mcap 49M€Healthcare & Pharma
Discover the full management transaction log of Interpace Biosciences, INC., a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Interpace Biosciences, INC. has published 2 public disclosures. Market capitalisation: €48.8m. The latest transaction was disclosed on 25 May 2021 (Acquisition). Among the most active insiders: Burnell Thomas W.. Every trade is accessible without an account.
2
Insider Decl.
0
Thresholds
€154,141
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
1.76 €
Analyst consensus
Income statement
Revenue38.7 M€
Gross profit24.1 M€62% margin
Net income24.6 M€65.2% margin
Valuation
PER (trailing)2.0x
P/Book1.7x
Balance sheet & cash
Market cap48.8 M€
Total debt1.2 M€
Free Cash Flow5.5 M€
Profitability & ownership
ROE213.9%
ROA10.6%
% insiders85.2%
% institutions0.0%
Last declaration on 25 May 2021
Declarations2 total
Executives▲Purchase26SEC
€77,07010,855 shares@ €7.10100.0% of flow
Common Stock
SEC:0001493152-21-012889·
Ideal exit: 15 Feb 2022 (T+270)
Executives▲Purchase44SEC
€77,07010,855 shares@ €7.100.16% mcap50.0% of flow
Common Stock
SEC:0001493152-21-012889:0·
Ideal exit: 15 Feb 2022 (T+270)
2 of 2 declarations
